compared once daily subcutaneous Semaglutide (0.1 mg, 0.2 mg, and 0.4 mg) to placebo in 320 patients with MASH and stage F1-3 fibrosis
The South Florida patient profile presenting at Perfect B frequently fits this description: desk-based professionals, patients who have tried dietary changes and exercise with limited visceral fat response, patients with pre-diabetic or borderline metabolic markers, and patients in their 40s and 50s experiencing the metabolic slowdown associated with declining mitochondrial function and declining MOTS-c production
[PubMed: 19159172] (Among 521 cases of drug induced liver injury submitted to Spanish registry, 13 [2%] were due to herbals, but none were attributed to a Hydroxycut product, green tea, ephedra or Ma Huang)
Yet for many adults over 35, quality sleep becomes progressively harder to achieve, and recovery from exercise or illness slows dramatically
Heart failure with reduced ejection fraction or recent decompensation: watch heart rate, volume status, and symptoms closely
Protein does more than just build muscle
